martes, 9 de abril de 2019

Oral, Head and Neck Cancer Awareness Month: Research Highlights - On Medicine

Michelle Feng He

Journal Development Editor at BMC

Michelle is a Journal Development Editor overseeing a portfolio of Oncology journals. She monitors and optimizes journal performance based on the needs of the authors, readers, and editors. She participates in data analyses that help identify the success metrics of individual journals or of larger development projects. Her interests are in multimedia tools—such as graphical abstracts, infographics, blogs, and podcasts—that further scientific exchange and engagement.

Oral, Head and Neck Cancer Awareness Month: Research Highlights

BMC supports Oral, Head and Neck Cancer Awareness month in April with a focused campaign week starting April 7th, led by the Head and Neck Cancer Alliance. In this blog, our Editors highlight some of the recent developments and emerging research areas on oral, head and neck cancers. This year, we’ve also created a quiz to complement these highlights and our author blog addressing Commonly Held Myths of Head and Neck Cancers.

Michelle Feng He 8 Apr 2019

Head and neck cancer accounts for 5–10% of all cancers in the United States and Europe.Oral, head and neck cancers are categorized by where they originate: either in squamous cells that line the head and neck or in the salivary glands. These cancers are then again subcategorized by the physical anatomy of where the cancer resides. An even more unique distinction is a sub-classification of head and neck cancers that is defined by an infection, Human Papillomavirus (HPV)-initiated oropharynx cancer. These HPV-associated cancers represent a different disease with different etiology, treatment tactics, and molecular profiling. This field of research is moving rapidly with new discoveries and challenges. We intend to impact the direction of research and clinical care in oral, head and neck cancer.